Point72 — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Hinge Bio is a biotechnology company developing next-generation therapeutics based on its GEM-DIMER platform, aimed at improving efficacy and reducing resistance and side effects.
BiotechHealthtechBurlingame, US
Daniel J. Capon(Director)Carin M. Rollins(Executive Officer, Director)Carin Mueller Rollins(Co-Founder & Chief Operating Officer)Harold E. Selick, PhD(Executive Officer, Director)Miriam Siekevitz(Executive Officer)Harold E. "Barry" Selick(Chief Executive Officer & Director)
Co-investorsBaruch Future VenturesInVivium CapitalAgent CapitalRidgeback Capital
Incognia provides device intelligence and identity verification solutions combining device recognition, location analysis, and tamper detection for fraud prevention and user verification.
AI & Machine LearningCybersecurityData & InfrastructureFintech
André F.(Founder)inAlan Gomes(Founder)in
Co-investorsBessemer Venture PartnersPoint72 VenturesValor Capital GroupFJ LabsProsus Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.